Efficacy of a Pseudomonas aeruginosa Serogroup O9 Vaccine

There are currently no approved vaccines against the opportunistic pathogen Pseudomonas aeruginosa. Among vaccine targets, the lipopolysaccharide (LPS) O antigen of P. aeruginosa is the most immunodominant protective candidate. There are twenty different O antigens composed of different repeat sugar...

Descripción completa

Detalles Bibliográficos
Autores principales: Moustafa, Dina A., DiGiandomenico, Antonio, Raghuram, Vishnu, Schulman, Marc, Scarff, Jennifer M., Davis,, Michael R., Varga, John J., Dean, Charles R., Goldberg, Joanna B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369961/
https://www.ncbi.nlm.nih.gov/pubmed/37502855
http://dx.doi.org/10.1101/2023.07.13.548830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369961/
https://www.ncbi.nlm.nih.gov/pubmed/37502855
http://dx.doi.org/10.1101/2023.07.13.548830

Ejemplares similares